Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
M.v. Ramana Reddy
Icahn School of Medicine at Mount Sinai, Department: Other Basic Sciences
Should you be removed from our database? Contact us at [email protected]. Read more below.
Onconova Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This study involves targeting mitotic kinases for cancer therapy. Dr. Ramana Reddy owns equity and receives financial compensation for providing consulting services to Onconova Therapeutics, Inc., and is a named inventor on an issued patent filed by Temple University and licensed to Onconova Therapeutics.
Targeting Mitotic Kinases Inhibitors for Cancer Therapy
This application describes the discovery of a novel cancer therapeutic agent, ON1231320, which could find a wide application in the treatment of some of the most difficult-to-treat cancers that are traditionally resistant to chemotherapy. In this application, we propose to develop preclinical pharmacology, and efficacy profiles for the ON1231320 in preparation to a Phase 1 study in cancer patients. Because this compound is highly effective in various combinations with conventional chemotherapy, the lack of bone marrow toxicity may be beneficial for testing novel combinations for advanced cancers, including tumors resistant to conventional chemotherapy.
Filed on January 31, 2013.
Tell us what you know about M.v. Ramana Reddy's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “M.v. Ramana Reddy”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| M.v. Ramana Reddy | Icahn School of Medicine at Mount Sinai | Conflict of Interest | Onconova Therapeutics, Inc. | $150,000 - $199,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.